Correlating functional staging to effective treatment of acute surgical illness

American Journal of Surgery

Volumn 182, Issue 3, 2001, Pages 278-286

  Nomikos, Iakovos N ^a,b   Vamvakopoulos, Nicholas C ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b University of Thessalia Medical School ^*  (Greece)

^c University of Thessaly School of Medicine   (Greece)

Author keywords

Acute surgical illness; Multiple organ failure; Systemic inflammatory response syndrome

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING INHIBITOR; CORTICOTROPIN; CYTOKINE; ENDOTOXIN ANTIBODY; GAMMA INTERFERON; GROWTH HORMONE; HIGH MOBILITY GROUP PROTEIN; IMMUNOGLOBULIN ANTIBODY; PENTOXIFYLLINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ACUTE SURGICAL ILLNESS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BIOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CRITICAL ILLNESS; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOLECULAR INTERACTION; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STAGING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034802558     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(01)00701-2     Document Type: Article

References (85)

1. Evolving concepts in the pathogenesis of post-injury multiple organ failure
2. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex
3. Supression of cellular immunity by surgical stress
4. Interactions between innate and adaptive immunity after injury
5. Prevention of post-ischemic lipid peroxidation and liver cell injury by iron chelation
6. Involvement of oxygen radicals in autoimmune diebetes
7. Proinflammatory cytokines (tumor necrosis factor and interleukin-1) stimulate release of high mobility group protein-1 by pituicytes
8. Revisiting the role of tumor necrosis factor and the response to surgical injury and inflammation
9. Sexual dimorphism of stress response and immune/inflammatory reaction: The corticotropin releasing hormone perspective
10. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure
11. Interleukin 10 (IL-10) inhibits cytokine synthesis by human myocytes: An autoregulatory role of IL-10 produced by monocytes
12. Interleukin 10 protects mice from lethal endotoxinemia
13. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxinemia
14. Recombinant human IL-11 attenuates the inflammatory response through down regulation of pro inflammatoty cytokine release and nitric oxide reduction
15. IL-11 enhances survival and decreases TNF production after radiation induced thoracic injury
16. The physiologic basis for anticytokine clinical trials in the treatment of sepsis
17. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL2): Prediction in patients with major trauma
18. Inadequate granulopoieses after major torso trauma. A hematopoietic regulatory paradox
19. Interleukin-6 delays neutrophil apoptosis
20. Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure
21. The local role of tumor necrosis factor-a in the modulation of neutrophil function at sites of inflammation
22. Mechanism of neutrophil-mediated tissue injury
23. PAF induced PMN superoxide production does not require PMN-EC adhesion
24. Increased PMN CD11b/CD18 expression following posttraumatic ARDS
25. Apoptosis: A different type of cell death
26. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2
27. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome
28. The Fas death factor
29. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
30. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
31. Calmodulin-dependent endothelium-derived relaxing factor/nitric synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells
32. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterine-dependent, calmodulin-independent, and inhibited by arginine analogues with a rank order of potency characteristic of activated macrophages
33. Control of IκB-proteolysis by site-specific signal-induced phosphorylation
34. Inhibition of the transcription factor nuclear factor-kB by adenoviral-mediated expression of IkBaM results in tumor cell death
35. Genes don't count
36. The discovery of nitric oxide in the vessel wall: A unifying concept in the biogenesis of sepsis
37. Alterations in nitric oxide production in various forms of circulatory shock
38. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus mediated gene transfer of the antiapoptotic Bcl-2 gene
39. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis
40. Apoptosis: Programmed cell death
41. Impoved clinical survival from sepsis
42. Enhanced urinary excretion of leukotriene E4 by patients with multiple trauma with or without adult respiratory distress syndrome
43. Increased PMN CD11b/CD18 expression following post-traumatic ARDS
44. Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome
45. Flow cytometric parameters of neutrophil function as early indicators of sepsis- or trauma-related pulmonary or cardiovascular organ failure
46. Modifying the host response to injury. The future of trauma care
47. Circuating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever
48. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk
49. HMG-1 as a late mediator of endotoxin lethality in mice
50. Definitions of sepsis and multiple organ failure
51. The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study
52. Postburn constitutional changes in T-cell reactivity occur in CD8+ rather than in CD4+ cells
53. T-cell reactivity and its predictive role in immunosuppression burns
54. Prevention of multiple organ failure
55. Current concepts: Treating patients with severe sepsis
56. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study
57. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein
58. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
59. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial
60. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
61. Interleukin 10 protects mice from lethal endotoxinemia
62. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxinemia
63. A randomized, controlled trial of IL-10 in humans
64. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production
65. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury
66. Immunomodulators: Inhibitors of adhesion
67. Human reconstituted high density lipoprotein attenuates the multiple organ dysfunction caused by endotoxin in rats
68. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
69. Organ apoptosis in the septic patient: A potential therapeutic target?
70. Prevention of lymphocyte cell death in sepsis improves survival in mice
71. Apoptosis in sepsis
72. Role of CuZn superoxide dismutase in regulating lymphocyte apoptosis during sepsis
73. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients: A review and a theoretical framework
74. The biology of inflammation
75. Immunonutrition in the critically ill: A systematic review of outcome
76. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery. A prospective randomized study
77. A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: Effect on host response and nutritional status
78. Immune dysfunction in trauma
79. Granylocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide and extracellular signal-regulated kinase pathways
80. The role of interferon gamma in preventive immunomodulation
81. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
82. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: Lessons learned from experimental and clinical studies
83. Methylene blue administration in septic shock: A clinical trial
84. Methylene blue increases myocardial function in septic shock
85. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome